Lumina Fund Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Lumina Fund Management’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-1,000	Closed	-$823K	–	41
2023 Q3	$823K	Hold	1,000	–	–	0.28%	28
2023 Q2	$719K	Hold	1,000	–	–	0.31%	34
2023 Q1	$822K	Hold	1,000	–	–	0.39%	27
2022 Q4	$721K	Hold	1,000	–	–	0.27%	26
2022 Q3	$689K	Hold	1,000	–	–	0.26%	23
2022 Q2	$591K	Hold	1,000	–	–	0.22%	29
2022 Q1	$698K	Sell	1,000 -800	-44%	-$506K	0.22%	32
2021 Q4	$1.14M	Hold	1,800	–	–	0.35%	14
2021 Q3	$1.09M	Hold	1,800	–	–	0.39%	14
2021 Q2	$1M	Hold	1,800	–	–	0.46%	15
2021 Q1	$852K	Buy	+1,800	New	+$876K	0.32%	20
2018 Q3	–	Sell	-13,000	Closed	-$4.49M	–	47
2018 Q2	$4.49M	Hold	13,000	–	–	0.45%	19
2018 Q1	$4.48M	Hold	13,000	–	–	0.4%	20
2017 Q4	$4.89M	Sell	13,000 -13,500	-51%	-$5.47M	0.45%	18
2017 Q3	$11.8M	Buy	26,500 +1,500	+6%	+$714K	1.22%	5
2017 Q2	$12.3M	Hold	25,000	–	–	0.8%	6
2017 Q1	$9.69M	Hold	25,000	–	–	1.21%	6
2016 Q4	$9.18M	Buy	25,000 +23,500	+1,567%	+$8.94M	0.97%	5
2016 Q3	$603K	Hold	1,500	–	–	0.06%	42
2016 Q2	$524K	Hold	1,500	–	–	0.04%	37
2016 Q1	$541K	Buy	+1,500	New	+$618K	0.06%	31
2014 Q4	–	Sell	-5,500	Closed	-$1.98M	–	51
2014 Q3	$1.98M	Sell	5,500 -19,200	-78%	-$6.44M	0.18%	32
2014 Q2	$6.98M	Buy	+24,700	New	+$7.32M	0.33%	8

Other funds holding REGN

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Lumina Fund Management's REGN Position: Q4 2023 in Review

Lumina Fund Management sold out of Regeneron Pharmaceuticals (REGN) in Q4 2023, closing a stake of 1,000 shares — an estimated $823K sold.

Lumina Fund Management first reported a position in REGN in Q2 2014 and held it in 23 quarters. The position peaked at $12.3M in Q2 2017. 1,272 funds tracked by Wall St. Rank hold REGN as of Q4 2023.

Lumina Fund Management reported no remaining Regeneron Pharmaceuticals position as of Q4 2023 after selling out during the quarter.
Lumina Fund Management sold 1,000 Regeneron Pharmaceuticals shares in Q4 2023, an estimated $823K.
Lumina Fund Management first reported a position in Regeneron Pharmaceuticals in Q2 2014 and held it in 23 quarters.
Lumina Fund Management's Regeneron Pharmaceuticals position peaked at $12.3M in Q2 2017.
1,272 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q4 2023.

Based on Lumina Fund Management's 13F filing for Q4 2023, filed 2 Feb 2024.